Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine combined with protective lung ventilation during one-lung ventilation
ChiCTR2000041525Phase 4Recruiting
- Sponsor
- Renmin Hospital, Hubei University of Medicine
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in not applicable; "lung injury" is not a specific disease (4 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoints: Alveolar-arterial oxygen partial pressure, Arterial partial pressure of oxygen and 8 more. Started Jan 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on ChiCTR2000041525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041525.